Data management

Iqvia launches new eCOA platform to quantify the patient experience

25-Jun-2019 By Melissa Fassbender

Iqvia today launched a new “patient centered endpoints” solution, which captures the patient experience during clinical trials and real world studies, says SVP.

Parexel taps into CluePoints risk monitoring to improve clinical data accuracy

25-Jun-2019 By Maggie Lynch

Parexel and CluePoints to use CSM solutions for preclinical and clinical risk-based monitoring, after regulatory guidelines impact mutual acceptance of data across the US, EU and Japan.

Signant Health CEO talks investments and growth opportunities a year after CRF, Bracket merger

24-Jun-2019 By Melissa Fassbender

CRF Bracket – newly-rebranded as Signant Health – is looking to build momentum around eConsent, rethink the patient’s connection to the supply chain, and build out a stronger analytics platform, says CEO.

Patient recruitment services market to reach $5.3bn by 2030

20-Jun-2019 By Melissa Fassbender

The patient recruitment and retention services market is predicted to reach a market value of $5.3bn by 2030, according to a recent report.

Merger creates ‘world’s largest’ biometrics provider

20-Jun-2019 By Maggie Lynch

Analytical software provider and CRO, Cytel, and biostatistics company, Axio Research, merge to deliver analytical solutions for clinical research drug development challenges.

Clinical trials center joins ProSciento’s program for NASH trial recruitment

20-Jun-2019 By Maggie Lynch

High Point Clinical Trials Center is partnering with ProSciento to accelerate clinical trial recruitment of patients with NASH and NAFLD.

Surrogate endpoints create potential, require statistical validation

19-Jun-2019 By Maggie Lynch

Transforming statistical data into a surrogate endpoint can enable comprehension of trial results sooner than usual, but few make the cut after formal validation, says drug development expert and DIA panelist.

Through the lens: Examining the opportunities and roles of females in clinical research

19-Jun-2019 By Maggie Lynch

Females as caregivers, clinical trial participants, and biopharma leaders are among the different roles to be carefully considered as the industry aims for increased inclusion, says BBK executive.

Artificial intelligence in drug development predicted to grow: DIA-Tufts study

19-Jun-2019 By Melissa Fassbender

In which areas is artificial intelligence most mature? What are the challenges to widespread adoption? Tufts and DIA recently teamed up to explore these questions.

Cognizant acquires Zenith to become single source provider

18-Jun-2019 By Maggie Lynch

Zenith-Cognizant Technologies emerges from an acquisition aimed to streamline solutions as more complex “smart factories” become a greater focus in the biopharmaceutical industry.

Alzheimer’s study looks to BYOD tech

18-Jun-2019 By Melissa Fassbender

Datacubed Health’s mobile platform has been selected to support a longitudinal Alzheimer’s study aimed at better understanding the disease and finding effective treatments.

MedNet expands global partnership program

17-Jun-2019 By Melissa Fassbender

MedNet's new program is aimed at accelerating clinical development using a combination of training tools and its eClinical platform.

Iqvia ‘unchallenged’ leads RWE market: Report

14-Jun-2019 By Melissa Fassbender

Iqvia leads the real world evidence market, which is at an inflection point, as pharma furthers its investment and vendors improve capabilities, according to a recent report.

Parexel teams with Clariness for patient recruitment in China

13-Jun-2019 By Maggie Lynch

Parexel forms a strategic partnership with Clariness to deploy the ClinLife platform in the Greater China area as the CRO looks to recruit and engage patients in their native language and via social media channels.

Medidata acquired by French software firm Dassault Systèmes for $5.8bn

12-Jun-2019 By Melissa Fassbender

Dassault Systèmes is set to acquire Medidata in an all-cash transaction valued at $5.8bn – a deal which will combine the power of modeling and simulation with data science to “catalyze the next generation of patient-inclusive therapeutics,” says CEO.